Check this out. I am going to offer you a choice today. You can either take away one very simple but important thought, set forth in the “Bottom Line” below, or you can spend almost an hour of your time watching the video you will be sent to via today’s URL. Be a sport and watch the video. I am sure that you will find it to be worthwhile.
Frankly, this one caught me by surprise. An absolute “DUH! Why didn’t I realize that?” experience. The panel discussion presented here centers around attaining three realizations. First, it is well recognized that in our race to eliminate inequity in healthcare, it is extremely important to have minority patients treated by practitioners who are “culturally sensitive” to their subgroup. Second, it is often impossible to have practitioners with the right language skills, cultural orientation, etc. available on site everywhere to meet this requirement. Third and finally, telehealth can be used to manage this challenge by providing access to “diverse providers,” and doing so efficiently.
Put all of this together and you have a great opportunity going hand in hand with an interesting challenge. The opportunity lies in being able to culturally “match” providers and patients. If a Black female patient wants to be treated by a Black female physician, that can be made to happen via telehealth. The challenge lies in figuring out what organization is going to set up the system that is going to make this all happen.
Spend an hour of your time listening to this panel discussion, and you might start to get an idea as to how all of this might work.
Bottom Line. A potentially significant application of telehealth is the ability to provide patients with access to culturally “diverse providers,” thus permitting better practitioner/patient interaction and better healthcare outcomes.
What role should the pharmaceutical industry play in making this happen???